Skip to main content
EVGN
NASDAQ Life Sciences

Evogene Reports Q2 and First Half 2026 Results Amid Activist Board Fight

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.56
Mkt Cap
$8.849M
52W Low
$0.37
52W High
$1.5
52W Position info
51% above low
Off High info
63% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

EVGN sits 51% above its 52-week low of $0.37 on light trading volume (0.2× avg).

Summary

Evogene reported second quarter and first half 2026 financial results. The company posted a second quarter loss per share of 67 cents and revenue of $681,000. The results come amid an ongoing activist board battle and a highly dilutive ATM offering. The market will focus on revenue trajectory and cash burn given the company's small market cap and going concern risks. This follows the Q1 loss of $5.87 million and revenue of $0.334 million reported in May.

At the time of this announcement, EVGN was trading at $0.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.8M. The 52-week trading range was $0.37 to $1.50. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info